NCT05097924View on ClinicalTrials.gov

Gastrointestinal Tolerability of a Partially Hydrolyzed Ready-to-feed Infant Formula in Healthy Newborns

CompletedOBSERVATIONAL
Enrollment

150

Participants

Timeline

Start Date

February 1, 2022

Primary Completion Date

March 9, 2022

Study Completion Date

March 9, 2022

Conditions
Infant Nutritional Physiological PhenomenaInfant Formula
Interventions
OTHER

NAN Supreme HypoAllergenic Starter Infant Formula in ready-to-feed format

Post-market observational study with formula feeding administered via standard of care

Trial Locations (1)

Unknown

Dr Sulaiman Al Habib Hospital, Riyadh

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY